Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Investigation of BRAF and CTNNB1 activating mutations in adrenocortical tumors.

Journal of endocrinological investigation - 1 Jul 2009

Masi G, Lavezzo E, Iacobone M, Favia G, Palù G, Barzon L

Abstract excerpt

BACKGROUND: Activating mutations of the BRAF oncogene play a central role in the development of various cancer types, but their role in human adrenocortical tumors is unknown. At variance, activating mutations of another oncogene, CTNNB1, which encodes beta-catenin, have been shown to be common e...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Cortex Neoplasms
Share to Aged
Share to beta Catenin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Transformation, Neoplastic

Share to DNA Mutational Analysis

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Young Adult

Source

Identifiers

PMID: 19498322
DOI: 10.1007/BF03346515

Genes

BRAF
CTNNB1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-19498322-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Investigation of BRAF and CTNNB1 activating mutations in adrenocortical tumors.PMID 19498322Read ↗

Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.Semantic proximity Read ↗

Mutational landscape of non-functional adrenocortical adenomas.Semantic proximity Read ↗

Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.Semantic proximity Read ↗

Mutational analysis of the BRAF, RAS and EGFR genes in human adrenocortical carcinomas.Semantic proximity Read ↗

Wnt/β-Catenin Pathway Activation in Adrenocortical Adenomas Is Frequently due to Somatic CTNNB1-Activating Mutations, Which Are Associated with Larger and Nonsecreting Tumors: A Study in Cortisol-Secreting and -Nonsecreting TumorsSemantic proximity Read ↗

Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas.Semantic proximity Read ↗

KIAA0101 is overexpressed, and promotes growth and invasion in adrenal cancer.Semantic proximity Read ↗

Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: Identification of novel mutations and correlation to survivalSemantic proximity Read ↗

Identification of Genetic Alterations of<i>AXIN2</i>Gene in Adrenocortical TumorsSemantic proximity Read ↗

CTNNB1Mutation in Aldosterone Producing AdenomaSemantic proximity Read ↗

Mutations in adrenocortical tumors.Semantic proximity Read ↗

Insights into the molecular biology of adrenocortical tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.